o_19nh7smpi1u37npm1scb1pfbjrda.pdf
6 Deals and Strategic Consolidations 6.1 Licensing Agreements 6.1.1 Major Licensing Deals 6.2 Co-development Agreements 6.2.1 Major Co-development Agreements 7 Appendix 7.1 All Pipeline Drugs by Phase 7.1.1 Discovery 7.1.2 Preclinical 7.1.3 IND/CTA-Filed 7.1.4 Phase I 7.1.5 Phase II 7.1.6 Phase III 7.2 Market Forecasts to 2020 7.2.1 Global 7.2.2 US 7.2.3 Canada 7.2.4 UK 7.2.5 France 7.2.6 Germany 7.2.7 Italy 7.2.8 Spain
7.2.9 Japan 7.3 Market Definitions 7.4 Abbreviations 7.5 References 7.6 Research Methodology 7.6.1 Coverage 7.6.2 Secondary Research 7.6.3 Primary Research 7.6.4 Therapeutic Landscape 7.6.5 Geographical Landscape 7.6.6 Pipeline Analysis 7.7 Expert Panel Validation 7.8 Contact Us 7.9 Disclaimer Latest Report: Polybutylene Succinate Market - Global Industry Expert Opinions Analysis, Emerging Opportunities, Market Size, Share, Growth Drivers, Market Trends, Statistics And Forecast 2015 – 2020 http://www.mrrse.com/polybutylene-succinate-market Description:
- Page 1 and 2: Colorectal Cancer Therapeutics Mark
- Page 3 and 4: 2 Introduction 2.1 Colorectal Cance
- Page 5: 4.8.7 Nintedanib - Boehringer Ingel
- Page 9: clients ahead of the next new trend
6 Deals and Strategic Consolidations<br />
6.1 Licensing Agreements<br />
6.1.1 Major Licensing Deals<br />
6.2 Co-development Agreements<br />
6.2.1 Major Co-development Agreements<br />
7 Appendix<br />
7.1 All Pipeline Drugs by Phase<br />
7.1.1 Discovery<br />
7.1.2 Preclinical<br />
7.1.3 IND/CTA-Filed<br />
7.1.4 Phase I<br />
7.1.5 Phase II<br />
7.1.6 Phase III<br />
7.2 Market Forecasts to 2020<br />
7.2.1 Global<br />
7.2.2 US<br />
7.2.3 Canada<br />
7.2.4 UK<br />
7.2.5 France<br />
7.2.6 Germany<br />
7.2.7 Italy<br />
7.2.8 Spain
Change language